Resources

OM1 Launches HS Dataset to Expand Use of Real-World Evidence in Dermatology

September 22, 2023

Practical Dermatology September 22, 2023 Read the full article >> OM1 is expanding its Dermatology Network to include almost 26,000 hidradenitis suppurativa (HS) patient records. “HS patients benefit when all available information on their journey can be surfaced and used to improve care and decision-making,” Joseph Zabinski tells DermWire. He is the Managing Director of AI and Personalized Medicine at OM1. “Much of this[…]

OM1 Launches Hidradenitis Suppurativa Dataset to Expand Real-World Evidence in Dermatology

September 21, 2023

Business Wire September 21, 2023 Read the full release >> BOSTON–(BUSINESS WIRE)–OM1 a leading real-world data, AI and technology company with a focus on chronic diseases, today announced the continued expansion of its Dermatology Network to include Hidradenitis Suppurativa (HS), a systemic inflammatory disease, enhancing the dataset with almost 26,000 patient records. Studies continue to show the link between[…]

The 2023 PharmaVoice 100 Awards Dr. Carl Marci

September 19, 2023

PharmaVoice Sept. 19. 2023 Read the full article >> The mental health crisis in the U.S. has reached a fever pitch with an estimated one in five adults experiencing some form of mental illness, according to the NIH. For Dr. Carl Marci, the dire need for new mental health solutions has propelled him throughout his 30-year[…]

Leveraging Real-World Data for Precision Obesity Treatment

September 7, 2023

Listen to the full podcast >> Healtheconmoncs.com July 26, 2023 On this episode of tHEORetically speaking features Gary Curhan, Chief Medical Officer and Jessica Paulus, Vice President of Research at OM1, as they answer questions on Leveraging Real-World Data for Precision Obesity Treatment.

OM1 Launches Parkinson’s Disease Premium Dataset to Expand Real-World Evidence in Neuroscience